ERGO
We are a biotech startup focused on the development of complex animal proteins by plant cell precision fermentation
We are a biotech startup focused on the development of complex animal proteins by plant cell precision fermentation
ERGO is a biotech startup that focuses on developing complex animal proteins using plant cell precision fermentation. The company leverages plant cells, which are considered the most sophisticated biological systems, to create a platform for programming multiple genetic modifications and mass production in bioreactors. This innovation represents a revolution in plant cells. ERGO has developed clones capable of expressing mammalian proteins, aiming to enhance plant foods' organoleptic and nutritional qualities. Established in 2020 and headquartered in the United States, ERGO recently secured a €1.50M Seed Round investment on 20 September 2023 from Mylkcubator and Global Agri-Food Advancement Partnership. With a mission to change the world, ERGO's innovative technology has the potential to positively contribute to this transformative vision within the Biopharma, Biotechnology, and Food and Beverage industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €1.50M | 3 |
|
20 Sep 2023 |
| Pre Seed Round | €225.00K | 1 |
|
12 Apr 2023 |
No recent news or press coverage available for ERGO.
We care about your data, and we'd love to use cookies make your experience better.
